// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Derivation of a Bronchial Airway Gene Expression Signature Associated with FEV1 Decline

E. J. Becker - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

Fluticasone

Interaction Between Exposures to Electronic Cigarette Vapors and Cigarette Smoke: Impacts on Pulmonary Leukocyte Populations and Lung Functions

A. Lechasseur - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Propylene glycol

Anti-Inflammatory Effects of Long-Acting Beta Agonists on Bronchial Epithelium

N. Yang - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Olodaterol

ATP Binding Cassette (ABC) Transporter Expression in Human Airway Epithelial Cells: A Meta-Analysis of Gene Expression from Bronchial Brushings

J. A. Hirota - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

Translationally Controlled Tumour Protein: A Novel Therapeutic Target for Lymphangioleiomyomatosis?

M. Ho - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

staurosporine

Comparison of Moral Distress and Burnout Among Residents in Specialty Programs

P. M. Dodek - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Methadone hydrochloride

Reducing Routine Blood Testing in the Medical-Surgical Intensive Care Unit: a Single Center Quality Improvement Study

J. Viau-Lapointe - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Improving the Appropriateness of Serum Magnesium Testing in an Intensive Care Unit

P. M. Dodek - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Nephrology

N/A

N/A

Assessment of Regional Perfusion in Acute Lung Injury Using Dual-Energy CT

Y. Xin - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

Iopamidol

Co-Exposure to Diesel Exhaust and Allergen Impairs Lung Function and Induces Local and Systemic Inflammation

D. Wooding - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

N/A

N/A

The RIFF Study (Cohort B): A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Lebrikizumab in Combination with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

T. M. Maher - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

Lebrikizumab

Unintentional Discontinuation of Respiratory Medications Following Hospitalization of Individuals with Chronic Obstructive Pulmonary Disease (COPD)

A. S. Gershon - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

Contemporary Incidence Rates of Venous Thromboembolism in Patients with Non-Small Cell Lung Cancer

D. C. Escobar Olaya - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Obstructive Sleep Apnea (OSA) and Obesity Increase Serum Levels of Inflammatory Adhesion Molecules

B. U. Peres - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

Alpha-Lipoic Acid Reduces Intermittent Hypoxia-Induced Renal Injury in a Mouse Model of Sleep Apnea

B. H. Abuyassin - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Alpha Lipoic Acid

Effect of Anti-Th2 Therapy on MRI Ventilation Heterogeneity in Prednisone-Dependent Asthma

S. L. Svenningsen - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Prednisone

Spirometry Is a Marker of General Health and Disability in the Elderly: The Canadian Longitudinal Study of Aging

J. M. Huang - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

Determining the Minimal Clinically Important Difference: MRI Ventilation Defect Percent in Asthmatics

R. Eddy - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

Computed Tomography Total Airway Count Predicts Disease Changes in the Quiet Zone in Severe COPD

M. Kirby - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

Oxidative Stress and Cell Death in Whole Body Low Dose X-Radiation Exposure in an In Vivo Model

S. Puukila - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved